BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.17), $0.08 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $36.2 million versus the consensus estimate of $38.2 million.

GUIDANCE:

BioLife Solutions sees FY2022 revenue of $159.5-171 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.